Noise in modern day life may be interfering with our ability to learn.
At a recent multigenerational family gathering, the millennials (and the boomers) were bemoaning the still-in-college-GenZs. “You get to learn all day. I miss that.” I would argue that those in the group that have jobs and responsibilities are still learning every day, but it’s a different learning because of said jobs and responsibilities. There is noise in our modern day life that can inhibit true learning over knee-jerk reactions.
There is probably no job or role today that doesn’t contain a modicum of learning. Whether it’s formal learning courses provided by your company, informal learning provided by your team, or personal learning during the course of your day, there are myriad opportunities from which to learn. But do we learn? Do we understand and incorporate the knowledge or information we have gleaned? Or are we too busy to get it and retain it?
In our article by Brian S. McGowan, PhD, as an expert in adult learning and change (his LinkedIn tagline is “Learning IS a Behavior”), outlines the three scientific fields that are fundamental in effective change management—learning, cognition, and behavioral economics. McGowan proposes that everyone can learn to change when best practices from these fields are integrated and leveraged to transform thinking and training approaches.
In the upcoming months, McGowan is going to share an article each on these three areas that offers a book for further reading, and an example of how it relates to clinical operations. Hopefully, this will lead to the stickiness of change management that is so desperately needed in our industry.
Sometimes, as I mentioned, the day-to-day is too overwhelming to take in new learnings. You’re too busy. The way you are doing things now works just fine. The way you relate to others is fine. You don’t understand why you need to learn this. It’s busy work.
But what if the way you are doing things is not optimal and there is a better way? What if the way you relate to others is causing unknown problems, and learning could make your work life more collaborative? And, finally, you may not know what you don’t know. Our business is about saving lives, and a little internal effort could go a long way in external realizations.
Lisa Henderson is Editor-in-Chief of Applied Clinical Trials and can be reached at lhenderson@mjhlifesciences.com.
Zenocutuzumab Shows Durable Efficacy in NRG1 Fusion-Positive Cancers in Phase II eNRGy Trial
February 13th 2025The Phase II eNRGy trial showed durable antitumor activity with zenocutuzumab (Bizengri) in patients with NRG1 fusion–positive cancers, particularly non-small cell lung cancer and pancreatic cancer.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
SCOPE Summit 2025: Enhancing the Patient Experience Through Site Centricity
February 12th 2025In an interview with ACT senior editor Andy Studna at SCOPE Summit, Ashley Davidson, vice president, product lead - sponsor tech strategy, Advarra, highlights the need for more site-centric approaches in study startup.